Clinical Trial Update: CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial evaluating CD45RA-depleted donor lymphocyte infusion after TCRα/β-depleted haploidentical hematopoietic cell transplantation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• CD45RA-depleted donor lymphocyte infusion (DLI)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Hematologic Malignancy | Phase 1, Phase 2 | Status: RECRUITING